BACKGROUND Rapid urinary trypsinogen-2 dipstick test and levels of urinary trypsinogen-2 and trypsinogen activation peptide(TAP) concentration have been reported as prognostic markers for the diagnosis of acute pancre...
Supported by KI-fonder at Karolinska Institutet,Bengt Ihre Foundation,Stockholm,Sweden;the Foundations of Researchat the University Hospital,Hedbergs Stiftelse and Mossbergs Stiftelse,Malm Sweden,Research Grants from the Stockholm County and Skane County Council(ALF)
AIM:To examine whether rendezvous endoscopic retrograde cholangiopancreatography(ERCP)is associated with less pancreatic damage,measured as leakage of proenzymes,than conventional ERCP.METHODS:Patients(n=122)with symp...
AIM: To evaluate the use of the trypsinogen-2 dipstick (Actim Pancreatitis) test for early diagnosis and prediction of severity in acute pancreatitis (AP). METHODS: Ninety-two patients with AP were included in t...
Supported by grants from the Institute de Salud Carlos III No.C03/02,No. G03/156
AIM: To assess the usefulness of urinary trypsinogen-2 test strip, urinary trypsinogen activation peptide (TAP),and serum and urine concentrations of the activation peptide of carboxypeptidase B (CAPAP) in the diagnos...